Back to Search Start Over

[No improvement of lipodystrophy syndrome in an HIV-infected patient].

Authors :
Lanzafame M
Faggian F
Lattuada E
Antolini D
Concia E
Source :
Recenti progressi in medicina [Recenti Prog Med] 2004 Jun; Vol. 95 (6), pp. 312-3.
Publication Year :
2004

Abstract

Lipodystrophy in patients with HIV-infection has been studied intensively to understand its epidemiology and pathophysiology. Recently its development was attributed to a dysregulation of TNF-alpha synthesis' homeostasis by HAART. A few years ago it was found that pentoxifylline decreases TNF-alpha production. We describe one HIV-infected patient, with lipodystrophy syndrome, treated with pentoxifylline without any improvement of lipodystrophic symptoms.

Subjects

Subjects :
Adult
HIV-Associated Lipodystrophy Syndrome chemically induced
HIV-Associated Lipodystrophy Syndrome metabolism
Humans
Male
Treatment Failure
Tumor Necrosis Factor-alpha metabolism
Antiretroviral Therapy, Highly Active adverse effects
HIV Infections drug therapy
HIV-Associated Lipodystrophy Syndrome drug therapy
Pentoxifylline therapeutic use
Tumor Necrosis Factor-alpha drug effects

Details

Language :
Italian
ISSN :
0034-1193
Volume :
95
Issue :
6
Database :
MEDLINE
Journal :
Recenti progressi in medicina
Publication Type :
Academic Journal
Accession number :
15248414

Tools

Authors Abstract Subjects Details